In contrast, HuR overexpression resulted in chemoresistance to standard glioma therapeutic agents such as etoposide, topotecan, and cisplatin by stabilizing BCL2 mRNA as well as enhancing translational efficiency. This evidence concerns the gene BCL2 and glioma.